Stocks to watch
Google's big bet on smartphones, AMD jumps on Tesla deal, Baidu launches self-driving car fund
| Previous Close | 65.79 |
| Open | 65.85 |
| Bid | 65.82 x 1000 |
| Ask | 65.83 x 1200 |
| Day's Range | 65.67 - 65.93 |
| 52 Week Range | 58.29 - 66.80 |
| Volume | 1,645,395 |
| Avg. Volume | 8,029,631 |
| Market Cap | 179.6B |
| Beta | 0.94 |
| PE Ratio (TTM) | 35.65 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.88 (2.85%) |
| Ex-Dividend Date | 2017-09-14 |
| 1y Target Est | N/A |
- Motley Fool•15 hours ago
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer has filed a suit against Johnson & Johnson alleging that it has engaged in anticompetitive behavior to block market demand for Pfizer's Remicade biosimilar.
- GuruFocus.com•19 hours ago
2 Important Dates for Big Pharma
Big PDUFA dates to watch for at the end of September
- InvestorPlace•3 days ago
Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear
Bristol-Myers Squibb Co (NYSE:BMY) stock has had a tumultuous 12-month period. In January, it fell 20% but luckily for the bulls it recovered all of it within five weeks. Since then and after several +/-8% moves, BMY is up 12% in 52 weeks which is decent but still underwhelming relative to the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) as a whole.Source: A 4 via Flickr
